STRATA Skin Sciences (NASDAQ:SSKN) Issues Earnings Results, Misses Estimates By $0.73 EPS

STRATA Skin Sciences (NASDAQ:SSKN) posted its quarterly earnings results on Thursday. The medical device company reported ($1.13) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.73), Zacks reports. STRATA Skin Sciences had a negative return on equity of 69.33% and a negative net margin of 28.72%.

STRATA Skin Sciences Price Performance

NASDAQ:SSKN traded up $0.03 during trading hours on Thursday, reaching $2.64. The stock had a trading volume of 2,388 shares, compared to its average volume of 12,188. The company has a 50 day moving average price of $2.76 and a two-hundred day moving average price of $2.92. STRATA Skin Sciences has a 52 week low of $2.51 and a 52 week high of $5.90. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.94 and a current ratio of 1.13. The stock has a market capitalization of $11.01 million, a PE ratio of -0.99 and a beta of 1.32.

Wall Street Analysts Forecast Growth

Separately, Maxim Group started coverage on shares of STRATA Skin Sciences in a research note on Thursday, February 27th. They set a “buy” rating and a $6.00 target price for the company.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.